Asunta Cirella

6PUBLICATIONS
45CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 02, 2023
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies.

Ignacio Melero, Maria C Ochoa, Carmen Molina

|Aug 18, 2023
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.

Javier Glez-Vaz, Arantza Azpilikueta, María C Ochoa

|Dec 08, 2022
Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity.

Assunta Cirella, Elixabet Bolaños, Claudia Augusta Di Trani

|Sep 21, 2022
Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy.

Alvaro Teijeira, Saray Garasa, Carlos Luri-Rey

|Jun 30, 2022
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β.

Irene Olivera, Rebeca Sanz-Pamplona, Elixabet Bolaños

|Jun 26, 2021
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic.

Iñaki Etxeberria, Elixabet Bolaños, Alvaro Teijeira

Pageof 1